Molecular and Electrophysiological Mechanisms Underlying Cardiac Arrhythmogenesis in Diabetes Mellitus

Journal of Diabetes Research

Volumn 2016, Issue , 2016, Pages

  Tse, Gary ^a   Lai, Eric Tsz Him ^b   Tse, Vivian ^c   Yeo, Jie Ming ^d  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c MCGILL UNIVERSITY   (Canada)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARRHYTHMOGENESIS; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART REPOLARIZATION; HUMAN; REVIEW; ACTION POTENTIAL; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; DEATH, SUDDEN, CARDIAC; METABOLISM; MYOCARDIAL ISCHEMIA; PATHOPHYSIOLOGY;

CALCIUM; ION CHANNEL;

ACTION POTENTIALS; ARRHYTHMIAS, CARDIAC; CALCIUM; CARDIOMYOPATHIES; DEATH, SUDDEN, CARDIAC; DIABETES MELLITUS; HUMANS; ION CHANNELS; MYOCARDIAL ISCHEMIA;

EID: 84974557965     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2016/2848759     Document Type: Review

References (88)

1. L. Choy, J. M. Yeo, V. Tse, S. P. Chan, and G. Tse, "Cardiac disease and arrhythmogenesis: mechanistic insights from mouse models," IJC Heart & Vasculature, vol. 12, pp. 1-10, 2016.
2. R. S. M. Chan and J. Woo, "Prevention of overweight and obesity: how effective is the current public health approach," International Journal of Environmental Research and Public Health, vol. 7, no. 3, pp. 765-783, 2010.
3. E. L. Yi Wong, J. Woo, E. Hui, C. Chan, W. L. S. Chan, and A. W. L. Cheung, "Primary care for diabetes mellitus: perspective from older patients," Patient Preference and Adherence, vol. 5, pp. 491-498, 2011.
4. G. Tse, S. T. Wong, V. Tse, and J. M. Yeo, "Monophasic action potential recordings: which is the recording electrode?" Journal of Basic and Clinical Physiology and Pharmacology, 2016.
5. G. Tse, E. T. H. Lai, J. M. Yeo et al., "Mechanisms of electrical activation and conduction in the gastrointestinal system: lessons fromcardiac electrophysiology," Frontiers in Physiology, vol. 7, article 182, 2016.
6. G. Tse, E. T. Lai, A. P. Lee, B. P. Yan, and S. H. Wong, "Electrophysiological mechanisms of gastrointestinal arrhythmogenesis: lessons from the heart," Frontiers in Physiology, vol. 7, article 230, 2016.
7. G. Tse, S. T. Wong, V. Tse, Y. T. Lee, H. Y. Lin, and J. M. Yeo, "Cardiac dynamics: alternans and arrhythmogenesis," Journal of Arrhythmia, 2016.
8. C. Desouza, H. Salazar, B. Cheong, J. Murgo, and V. Fonseca, "Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring," Diabetes Care, vol. 26, no. 5, pp. 1485-1489, 2003.
9. J. L. B. Marques, E. George, S. R. Peacey et al., "Altered ventricular repolarization during hypoglycaemia in patients with diabetes," Diabetic Medicine, vol. 14, no. 8, pp. 648-654, 1997.
10. R. Bolognesi, D. Tsialtas, M. G. Bolognesi, and C. Giumelli, "Marked sinus bradycardia and QT prolongation in a diabetic patient with severe hypoglycemia," Journal of Diabetes and its Complications, vol. 25, no. 5, pp. 349-351, 2011.
11. G. Tse, E. T. H. Lai, J. M. Yeo, and B. P. Yan, "Electrophysiological mechanisms of Bayés syndrome: insights from clinical and mouse studies," Frontiers in Physiology, vol. 7, article 188, 2016.
12. P. Coumel, "Cardiac arrhythmias and the autonomic nervous system," Journal of Cardiovascular Electrophysiology, vol. 4, no. 3, pp. 338-355, 1993.
13. R. B. Tattersall and G. V. Gill, "Unexplained deaths of Type 1 diabetic patients," Diabetic Medicine, vol. 8, no. 1, pp. 49-58, 1991.
14. G. Tse and J. M. Yeo, "Conduction abnormalities and ventricular arrhythmogenesis: the roles of sodium channels and gap junctions," IJC Heart & Vasculature, vol. 9, pp. 75-82, 2015.
15. A. P. Moreno, J.C. Sáez, G. I. Fishman, and D. C. Spray, "Human connexin43 gap junction channels: regulation of unitary conductances by phosphorylation," Circulation Research, vol. 74, no. 6, pp. 1050-1057, 1994.
16. B.R. Kwak, M. M. P. Hermans, H. R. De Jonge, S. M. Lohmann, H. J. Jongsma, and M. Chanson, "Differential regulation of distinct types of gap junction channels by similar phosphorylating conditions," Molecular Biology of the Cell, vol. 6, no. 12, pp. 1707-1719, 1995.
17. M.A. Beardslee, D.L. Lerner, P. N. Tadros et al., "Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia," Circulation Research, vol. 87, no. 8, pp. 656-662, 2000.
18. J. H. Smith, C. R. Green, N. S. Peters, S. Rothery, and N. J. Severs, "Altered patterns of gap junction distribution in ischemic heart disease: an immunohistochemical study of humanmyocardium using laser scanning confocal microscopy," American Journal of Pathology, vol. 139, no. 4, pp. 801-821, 1991.
19. P. D. Lampe, E. M. Ten Broek, J. M. Burt, W. E. Kurata, R. G. Johnson, and A. F. Lau, "Phosphorylation of connexin43 on serine368 by protein kinase C regulates gap junctional communication," The Journal of Cell Biology, vol. 149, no. 7, pp. 1503-1512, 2000.
20. J. P. Morrow, A. Katchman, N.-H. Son et al., "Mice with cardiac overexpression of peroxisome proliferator-activated receptor γ have impaired repolarization and spontaneous fatal ventricular arrhythmias," Circulation, vol. 124, no. 25, pp. 2812-2821, 2011.
21. F. C. Howarth, N. Nowotny, E. Zilahi, M. A. El Haj, and M. Lei, "Altered expression of gap junction connexin proteins may partly underlie heart rhythm disturbances in the streptozotocin-induced diabetic rat heart," Molecular and Cellular Biochemistry, vol. 305, no. 1-2, pp. 145-151, 2007.
22. H. Lin, M. Mitasikova, K. Dlugosova et al., "Thyroid hormones suppress ∈-PKC signalling, down-regulate connexin-43 and increase lethal arrhythmia susceptibility in non-diabetic and diabetic rat hearts," Journal of Physiology and Pharmacology, vol. 59, no. 2, pp. 271-285, 2008.
23. M. Mitašíková, H. Lin, T. Soukup, I. Imanaga, and N. Tribulová, "Diabetes and thyroid hormones affect connexin-43 and PKC-∈ expression in rat heart atria," Physiological Research, vol. 58, no. 2, pp. 211-217, 2009.
24. J. Asbun and F. J. Villarreal, "The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy," Journal of the American College of Cardiology, vol. 47, no. 4, pp.693-700, 2006.
25. A. Leask, "Potential therapeutic targets for cardiac fibrosis: TGFβ, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation," Circulation Research, vol. 106, no. 11, pp. 1675-1680, 2010.
26. M. Miragoli, G. Gaudesius, and S. Rohr, "Electrotonic modulation of cardiac impulse conduction by myofibroblasts," Circulation Research, vol. 98, no. 6, pp. 801-810, 2006.
27. G. Tse, A. Ali, F. Alpendurada, S. Prasad, C. E. Raphael, and V. Vassiliou, "Tuberculous constrictive pericarditis," Research in Cardiovascular Medicine, vol. 4, no. 4, Article ID e29614, 2015.
28. G. Tse, A. Ali, S. K. Prasad, V. Vassiliou, and C. E. Raphael, "Atypical case of post-partum cardiomyopathy: an overlap syndrome with arrhythmogenic right ventricular cardiomyopathy?" BJR: Case Reports, vol. 1, no. 2, Article ID 20150182, 2015.
29. V. Vassiliou, C. Chin, A. Perperoglou et al., "93 Ejection fraction by cardiovascular magnetic resonance predicts adverse outcomes post aortic valve replacement," Heart, vol. 100, supplement 3, pp. A53-A54, 2014.
30. J.-H. Luo and I. B. Weinstein, "Calcium-dependent activation of protein kinase C: the role of the C2 domain in divalent cation selectivity," The Journal of Biological Chemistry, vol. 268, no. 31, pp. 23580-23584, 1993.
31. Y. Qu, J. C. Rogers, T. N. Tanada, W. A. Catterall, and T. Scheuer, "Phosphorylation of S1505 in the cardiac Na+ channel inactivation gate is required for modulation by protein kinase C," Journal of General Physiology, vol. 108, no. 5, pp. 375-379, 1996.
32. X.-D. Huang, G. E. Sandusky, and D. P. Zipes, "Heterogeneous loss of connexin43 protein in ischemic dog hearts," Journal of Cardiovascular Electrophysiology, vol. 10, no. 1, pp. 79-91, 1999.
33. E. Carmeliet, "Cardiac ionic currents and acute ischemia: from channels to arrhythmias," Physiological Reviews, vol. 79, no. 3, pp. 917-1017, 1999.
34. Kr potassiumchannel," Cell, vol. 81, no. 2, pp. 299-307, 1995.
35. A. Lopez-Izquierdo, R. O. Pereira, A. R. Wende, B. B. Punske, E. Dale Abel, and M. Tristani-Firouzi, "The absence of insulin signaling in the heart induces changes in potassium channel expression and ventricular repolarization," American Journal of Physiology-Heart and Circulatory Physiology, vol. 306, no. 5, pp. H747-H754, 2014.
36. G. Tse, B. P. Yan, Y. W. F. Chan, X. Y. Tian, and Y. Huang, "Reactive oxygen species, endoplasmic reticulum stress and mitochondrial dysfunction: the link with cardiac arrhythmogenesis," Frontiers in Physiology, vol. 7, article 313, 2016.
37. + channel activity," Circulation Research, vol. 103, no. 3, pp. 269-278, 2008.
38. 2+ channels in the heart," Circulation Research, vol. 101, no. 1, pp. 69-77, 2007.
39. Z. Hu, R. Kant, M. Anand et al., "Kcne2 deletion creates a multisystem syndrome predisposing to sudden cardiac death," Circulation: Cardiovascular Genetics, vol. 7, no. 1, pp. 33-42, 2014.
40. + channel function by hypoglycemia and hyperglycemia: similar phenotypes but differentmechanisms," The Journal of Biological Chemistry, vol. 278, no. 12, pp. 10417-10426, 2003.
41. C. Xie, J. Hu, L. J. Motloch, B. S. Karam, and F. G. Akar, "The classically cardioprotective agent diazoxide elicits arrhythmias in type 2 diabetes mellitus," Journal of the American College of Cardiology, vol. 66, no. 10, pp. 1144-1156, 2015.
42. S. R. Heller and R. T. C. E. Robinson, "Hypoglycaemia and associated hypokalaemia in diabetes: mechanisms, clinical implications and prevention," Diabetes, Obesity and Metabolism, vol. 2, no. 2, pp. 75-82, 2000.
43. T. F. Christensen, M. Bækgaard, J. L. Dideriksen et al., "A physiological model of the effect of hypoglycemia on plasma potassium," Journal of Diabetes Science and Technology, vol. 3, no. 4, pp. 887-894, 2009.
44. B. M. Fisher, I. Thomson, D. A. Hepburn, and B. M. Frier, "Effects of adrenergic blockade on serum potassium changes in response to acute insulin-induced hypoglycemia in nondiabetic humans," Diabetes Care, vol. 14, no. 7, pp. 548-552, 1991.
45. K.G. Petersen, K. J. Schluter, and L. Kerp, "Regulation of serum potassium during insulin-induced hypoglycemia," Diabetes, vol. 31, no. 7, pp. 615-617, 1982.
46. C. T. January and J. M. Riddle, "Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current," Circulation Research, vol. 64, no. 5, pp. 977-990, 1989.
47. G. Tse, V. Tse, J. M. Yeo, B. Sun, and A. Talkachova, "Atrial antiarrhythmic effects of heptanol in Langendorff-perfused mouse hearts," PLoS ONE, vol. 11, no. 2, Article IDe0148858, 2016.
48. G. Tse, S. T. Wong, V. Tse, and J. Yeo, "Restitution analysis of alternans using dynamic pacing and its comparison with S1S2 restitution in heptanol-treated, hypokalaemic Langendorffperfused mouse hearts," Biomedical Reports, vol. 4, no. 6, pp. 673-680, 2016.
49. Y.-C. Hsieh, J.-C. Lin, C.-Y. Hung et al., "Gap junction modifier rotigaptide decreases the susceptibility to ventricular arrhythmia by enhancing conduction velocity and suppressing discordant alternans during therapeutic hypothermia in isolated rabbit hearts," Heart Rhythm, vol. 13, no. 1, pp. 251-261, 2016.
50. A. Goldfien, R. Moore, S. Zileli, L. L. Havens, L. Boling, and G. W. Thorn, "Plasma epinephrine and norepinephrine levels during insulin-induced hypoglycemia in man," The Journal of clinical endocrinology & metabolism, vol. 21, pp. 296-304, 1961.
51. 2+ handling defects in cardiomyocytes of ob/ob mice," Diabetes, vol. 54, no. 8, pp. 2375-2381, 2005.
52. J. Fauconnier, J. T. Lanner, A. Sultan et al., "Insulin potentiates TRPC3-mediated cation currents in normal but not in insulinresistant mouse cardiomyocytes," Cardiovascular Research, vol. 73, no. 2, pp. 376-385, 2007.
53. 2+ release in myocytes fromstreptozotocin-induced diabetic rats," Journal of Molecular and Cellular Cardiology, vol. 42, no. 1, pp. 234-246, 2007.
54. C.-H. Shao, X. H. T. Wehrens, T. A. Wyatt et al., "Exercise training during diabetes attenuates cardiac ryanodine receptor dysregulation," Journal of Applied Physiology, vol. 106, no. 4, pp. 1280-1292, 2009.
55. J. Hain, H. Onoue, M. Mayrleitner, S. Fleischer, and H. Schindler, "Phosphorylation modulates the function of the calciumrelease channel of sarcoplasmic reticulumfrom cardiac muscle," The Journal of Biological Chemistry, vol. 270, no. 5, pp. 2074-2081, 1995.
56. 2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor," Circulation Research, vol. 94, no. 6, pp. e61-e70, 2004.
57. D. B. Witcher, R. J. Kovacs, H. Schulman, D. C. Cefali, and L. R. Jones, "Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity," The Journal of Biological Chemistry, vol. 266, no. 17, pp. 11144-11152, 1991.
58. K. R. Bidasee, K. Nallani, H. R. Besch Jr., and U. Deniz Dincer, "Streptozotocin-induced diabetes increases disulfide bond formation on cardiac ryanodine receptor (RyR2)," Journal of Pharmacology and Experimental Therapeutics, vol. 305, no. 3, pp. 989-998, 2003.
59. 2+-release channels from sheep myocardium," The American Journal of Physiology, vol. 272, no. 6, part 1, pp. C1908-C1918, 1997.
60. L. Xu, J. P. Eu, G. Meissner, and J. S. Stamler, "Activation of the cardiac calcium release channel (ryanodoine receptor) by poly-S-nitrosylation," Science, vol. 279, no. 5348, pp. 234-237, 1998.
61. J. R. Erickson, L. Pereira, L. Wang et al., "Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation," Nature, vol. 502, no. 7471, pp. 372-376, 2013.
62. L.-S. Song, E. A. Sobie, S. McCulle, W. J. Lederer, C. W. Balke, and H. Cheng, "Orphaned ryanodine receptors in the failing heart," Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 11, pp. 4305-4310, 2006.
63. G. Santulli, G. Pagano, C. Sardu et al., "Calcium release channel RyR2 regulates insulin release and glucose homeostasis," The Journal of Clinical Investigation, vol. 125, no. 5, pp. 1968-1978, 2015.
64. F. Yi, T.-Y. Ling, T. Lu et al., "Down-regulation of the small conductance calcium-activated potassium channels in diabetic mouse atria," The Journal of Biological Chemistry, vol. 290, no. 11, pp. 7016-7026, 2015.
65. P.-C. Chang and P.-S. Chen, "SK channels and ventricular arrhythmias in heart failure," Trends in Cardiovascular Medicine, vol. 25, no. 6, pp. 508-514, 2015.
66. E. Soltysinska, T. Speerschneider, S. V. Winther, and M. B. Thomsen, "Sinoatrial node dysfunction induces cardiac arrhythmias in diabetic mice," Cardiovascular Diabetology, vol. 13, no. 1, article 122, 2014.
67. C. Basso, F. Calabrese, A. Angelini, E. Carturan, and G. Thiene, "Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease," Heart Failure Reviews, vol. 18, no. 6, pp. 673-681, 2013.
68. K. Fukuda, H. Kanazawa, Y. Aizawa, J. L. Ardell, and K. Shivkumar, "Cardiac innervation and sudden cardiac death," Circulation Research, vol. 116, no. 12, pp. 2005-2019, 2015.
69. F. Lombardi, "Chaos theory, heart rate variability, and arrhythmic mortality," Circulation, vol. 101, no. 1, pp. 8-10, 2000.
70. M. Rajab, H. Jin, C. M. Welzig et al., "Increased inducibility of ventricular tachycardia and decreased heart rate variability in a mousemodel for type 1 diabetes: effect of pravastatin," American Journal of Physiology-Heart and Circulatory Physiology, vol. 305, no. 12, pp. H1807-H1816, 2013.
71. L. Ligeti, O. Szenczi, C. M. Prestia et al., "Altered calcium handling is an early sign of streptozotocin-induced diabetic cardiomyopathy," International Journal of Molecular Medicine, vol. 17, no. 6, pp. 1035-1043, 2006.
72. J. Amour, X. Loyer, P. Michelet, A. Birenbaum, B. Riou, and C. Heymes, "Preservation of the positive lusitropic effect of β-adrenoceptors stimulation in diabetic cardiomyopathy," Anesthesia & Analgesia, vol. 107, no. 4, pp. 1130-1138, 2008.
73. C. Hasslacher and P. Wahl, "Diabetes prevalence in patientswith bradycardiac arrhythmias," Acta Diabetologica Latina, vol. 14, no. 5-6, pp. 229-234, 1977.
74. M.-R. Movahed, M. Hashemzadeh, and M. M. Jamal, "Increased prevalence of third-degree atrioventricular block in patients with type II diabetes mellitus," Chest, vol. 128, no. 4, pp. 2611-2614, 2005.
75. G. S. Hillis, M. Woodward, A. Rodgers et al., "Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus," Diabetologia, vol. 55, no. 5, pp. 1283-1290, 2012.
76. P. S. Krishnaswamy, E. E. Egom, M. Moghtadaei et al., "Altered parasympathetic nervous system regulation of the sinoatrial node in Akita diabetic mice," Journal of Molecular and Cellular Cardiology, vol. 82, pp. 125-135, 2015.
77. B. Yan, L. Li, S. W. Harden et al., "Diabetes induces neural degeneration in nucleus ambiguus (NA) and attenuates heart rate control in OVE26 mice," Experimental Neurology, vol. 220, pp. 34-43, 2009.
78. M. Ieda, K. Kimura, H. Kanazawa, and K. Fukuda, "Regulation of cardiac nerves: a newparadigm in themanagement of sudden cardiac death?" Current Medicinal Chemistry, vol. 15, no. 17, pp. 1731-1736, 2008.
79. + currents in type 1 and type 2 diabetes," Journal of Physiology, vol. 537, no. 1, pp. 83-92, 2001.
80. M. Pahor, R. Bernabei, A. Sgadari et al., "Enalapril prevents cardiac fibrosis and arrhythmias in hypertensive rats," Hypertension, vol. 18, no. 2, pp. 148-157, 1991.
81. G. Gay-Jordi, E. Guash, B. Benito et al., "Losartan prevents heart fibrosis induced by long-term intensive exercise in an animal model," PLoS ONE, vol. 8, no. 2, Article ID e55427, 2013.
82. R. A. D. Bathgate, E. D. Lekgabe, J. T. McGuane et al., "Adenovirus-mediated delivery of relaxin reverses cardiac fibrosis," Molecular and Cellular Endocrinology, vol. 280, no. 1-2, pp. 30-38, 2008.
83. A. S. Alves Bento, D. Bacic, J. Saran Carneiro et al., "Selective late INa inhibition by GS-458967 exerts parallel suppression of catecholamine-induced hemodynamically significant ventricular tachycardia and T-wave alternans in an intact porcine model," Heart Rhythm, vol. 12, no. 12, pp. 2508-2514, 2015.
84. S. E. Lehnart, C. Terrenoire, S. Reiken et al., "Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias," Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 20, pp. 7906-7910, 2006.
85. i underlie intermittent early afterdepolarizations and arrhythmias," Circulation: Arrhythmia and Electrophysiology, vol. 8, no. 6, pp. 1472-1480, 2015.
86. G. Tse, V. Tse, and J.M. Yeo, "Ventricular anti-arrhythmic effects of heptanol in hypokalaemic, Langendorff-perfused mouse hearts," Biomedical Reports, vol. 4, no. 3, pp. 313-324, 2016.
87. G. Tse, J. M. Yeo, Y.W. Chan, E. T. Lai, and B. P. Yan, "What is the arrhythmic substrate in viral myocarditis? Insights from clinical and animal studies," Frontiers in Physiology, vol. 7, article 308, 2016.
88. G. Tse, "(Tpeak-Tend)/QRS and (Tpeak-Tend)/(QT x QRS): novel markers for predicting arrhythmic risk in Brugada syndrome," Europace, 2016.